Growth Metrics

Strata Critical Medical (SRTA) Preferred Stock Liabilities (2019 - 2021)

Strata Critical Medical (SRTA) has disclosed Preferred Stock Liabilities for 3 consecutive years, with $225.0 million as the latest value for Q1 2021.

  • Quarterly Preferred Stock Liabilities fell 10.82% to $225.0 million in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $225.0 million through Mar 2021, down 10.82% year-over-year, with the annual reading at $226.1 million for FY2020, N/A changed from the prior year.
  • Preferred Stock Liabilities for Q1 2021 was $225.0 million at Strata Critical Medical, roughly flat from $226.1 million in the prior quarter.
  • The five-year high for Preferred Stock Liabilities was $252.3 million in Q1 2020, with the low at $225.0 million in Q1 2021.
  • Average Preferred Stock Liabilities over 3 years is $241.2 million, with a median of $244.6 million recorded in 2020.
  • The sharpest move saw Preferred Stock Liabilities increased 0.24% in 2020, then dropped 10.82% in 2021.
  • Over 3 years, Preferred Stock Liabilities stood at $246.6 million in 2019, then decreased by 8.32% to $226.1 million in 2020, then decreased by 0.48% to $225.0 million in 2021.
  • According to Business Quant data, Preferred Stock Liabilities over the past three periods came in at $225.0 million, $226.1 million, and $244.6 million for Q1 2021, Q4 2020, and Q3 2020 respectively.